Restricted mean survival time in patients with chronic lymphocytic leukemia treated with chemotherapy-free regimens as first line

被引：0
|
作者：
Messori, Andrea [1 ]
Bartoli, Laura [1 ]
机构：
[1] HTA Unit & Reg Toscana, Estar Toscana, Via San Salvi 12, I-50135 Florence, Italy
来源：
LEUKEMIA & LYMPHOMA | 2021年 / 62卷 / 04期
关键词：
D O I：
10.1080/10428194.2020.1845337
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1018 / 1018
页数：1
相关论文
共 50 条
  • [1] Chemotherapy-free treatment of chronic lymphocytic leukemia?
    Wendtner, C. -M.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (41) : 2104 - 2106
  • [2] Chronic lymphocytic Leukemia Chemotherapy-free Regimes in Sight
    Pickl, Susanne
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (12) : 793 - 793
  • [3] First-line treatments for chronic lymphocytic leukemia: Analysis of 7 trials based on the restricted mean survival time
    Bartoli, Laura
    Ferracane, Elisa
    Trippoli, Sabrina
    Messori, Andrea
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (04) : 322 - 327
  • [4] Temporary, chemotherapy-free Option for chronic lymphocytic Leukemia Venetoclax Combination Therapy: Extension of approval for the First Line
    Ruedesheim, Sabine M.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (06)
  • [5] Outcomes of first line chemotherapy in patients with chronic lymphocytic leukemia
    Nazir, Adil
    Fawad
    Ali, Sheeraz
    Badar, Farhana
    Siddique, Neelam
    Hameed, Abdul
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2016, 32 (05) : 1213 - 1217
  • [6] Towards control of chronic lymphocytic leukemia using chemotherapy-free combinations
    Hallek, Michael
    HEMASPHERE, 2018, 2 : 51 - 52
  • [7] Molecular Management of Chronic Lymphocytic Leukemia: Towards a Chemotherapy-Free Approach
    Sayinalp, Nilgun
    Haznedaroglu, Ibrahim C.
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2016, 26 (01): : 1 - 11
  • [8] Comparative Efficacy of First-Line Chemotherapy-Free Combinations in Chronic Lymphocytic Leukemia (CLL): A Network Meta-Analysis
    Haddad, Philip A.
    Ganey, Nowell
    Gallagher, Kevin M.
    BLOOD, 2020, 136
  • [9] Alemtuzumab maintenance may safely prolong chemotherapy-free intervals in chronic lymphocytic leukemia
    Matthew S. Kaufman
    Angelica Caramanica
    Dale Janson
    Nancy Driscoll
    Christina Johnson
    Nina Kohn
    Tarun Wasil
    Kanti R. Rai
    Medical Oncology, 2011, 28 : 532 - 538
  • [10] Alemtuzumab maintenance may safely prolong chemotherapy-free intervals in chronic lymphocytic leukemia
    Kaufman, Matthew S.
    Caramanica, Angelica
    Janson, Dale
    Driscoll, Nancy
    Johnson, Christina
    Kohn, Nina
    Wasil, Tarun
    Rai, Kanti R.
    MEDICAL ONCOLOGY, 2011, 28 (02) : 532 - 538
12345